Home Stock

Stock Research: Ono Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Ono Pharmaceutical

TYO:4528 JP3197600004
100
  • Value
    92
  • Growth
    90
  • Safety
    Safety
    74
  • Combined
    98
  • Sentiment
    63
  • 360° View
    360° View
    100
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company that manufactures and sells pharmaceuticals. The company operates in the pharmaceutical industry. ONO PHARMACEUTICAL CO., LTD. operates primarily in Japan. In the last fiscal year, the company had a market cap of $5,561 million, profits of $2,260 million, revenue of $3,247 million, and 4287 employees.

more

ANALYSIS: With an Obermatt 360° View of 100 (better than 100% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Ono Pharmaceutical are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Ono Pharmaceutical. The consolidated Value Rank has an attractive rank of 92, which means that the share price of Ono Pharmaceutical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 92% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 90, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 74. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 63. ...read more

more
Strongest Rank Analyst Opinions
Weakest Rank 360° View
Country Japan
Industry Pharmaceuticals
Size Large
Website ono-pharma.com
Index
Ono Pharmaceutical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 23-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
92 94 84 65
Growth
90 22 11 57
Safety
Safety
74 95 90 82
Sentiment
63 6 32 31
360° View
360° View
100 61 55 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
5 1 5 41
Opinions Change
50 35 50 40
Pro Holdings
n/a 10 70 82
Market Pulse
61 46 44 12
Sentiment
63 6 32 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
92 94 84 65
Growth
90 22 11 57
Safety Safety
74 95 90 82
Combined
98 89 75 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
41 69 41 39
Price vs. Earnings (P/E)
61 88 100 89
Price vs. Book (P/B)
85 88 62 61
Dividend Yield
95 91 89 77
Value
92 94 84 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
12 41 10 76
Profit Growth
86 4 54 52
Capital Growth
93 79 32 17
Stock Returns
77 8 19 55
Growth
90 22 11 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
72 83 85 80
Refinancing
37 73 51 39
Liquidity
74 97 98 96
Safety Safety
74 95 90 82

Similar Stocks

Discover high‑ranked alternatives to Ono Pharmaceutical and broaden your portfolio horizons.

Inpex

TYO:1605
Country: Japan
Industry: Oil & Gas Production
Size: X-Large
Full Stock Analysis

Kinden

TYO:1944
Country: Japan
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

Shionogi

TYO:4507
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

NGK Insulators

TYO:5333
Country: Japan
Industry: Industrial Machinery
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews